Long-term Survival Benefit of Eculizumab Treatment in Patients With Paroxysmal Nocturnal Haemoglobinuria: Data From the International PNH Registry

被引：0
|
作者：
Griffin, Morag [1 ]
Terriou, Louis [2 ]
Patriquin, Christopher J. [3 ]
Lee, Jong Wook [4 ]
Gustovic, Philippe [5 ]
Patel, Ami S. [6 ]
Szer, Jeff [7 ,8 ]
机构：
[1] Leeds Teaching Hosp NHS Trust, Dept Haematol, Leeds, W Yorkshire, England
[2] CHU Lille, Serv Med Interne & Immunol Clin, Lille, France
[3] Univ Toronto, Univ Hlth Network, Div Med Oncol & Hematol, Toronto, ON, Canada
[4] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Hematol, Seoul, South Korea
[5] Alex, AstraZeneca Rare Dis, Zurich, Switzerland
[6] Alex, AstraZeneca Rare Dis, Boston, MA USA
[7] Peter MacCallum Canc Ctr, Dept Clin Haematol, Melbourne, Vic, Australia
[8] Royal Melbourne Hosp, Melbourne, Vic, Australia
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2022年 / 197卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
BSH22-OR06
引用
收藏
页码：8 / 9
页数：2
相关论文
共 50 条
  • [41] Management of pregnancy in paroxysmal nocturnal hemoglobinuria on long-term eculizumab
    Vekemans, Marie-Christiane
    Lambert, Catherine
    Ferrant, Augustin
    Saussoy, Pascale
    Havelange, Violaine
    Debieve, Frederic
    Van den Neste, Eric
    Michaux, Lucienne
    BLOOD COAGULATION & FIBRINOLYSIS, 2015, 26 (04) : 464 - 466
  • [42] Chronic Renal Insufficiency in Japanese Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH): Improvement with Eculizumab Treatment in the Long-Term Follow-up of the AEGIS Study
    Kanakura, Yuzuru
    Ohyashiki, Kazuma
    Shichishima, Tsutomu
    Okamoto, Shinichiro
    Ando, Kiyoshi
    Ninomiya, Haruhiko
    Kawaguchi, Tatsuya
    Nakao, Shinji
    Nakakuma, Hideki
    Nishimura, Jun-ichi
    Kinoshita, Taroh
    Bedrosian, Camille
    Valentine, Marye Ellen
    Ozawa, Keiya
    Omine, Mitsuhiro
    BLOOD, 2009, 114 (22) : 783 - 784
  • [43] Assessment of human antihuman antibodies to eculizumab after long-term treatment in patients with paroxysmal nocturnal hemoglobinuria
    Hillmen, Peter
    Muus, Petra
    Szer, Jeffrey
    Hill, Anita
    Hoechsmann, Britta
    Kulasekararaj, Austin
    Risitano, Antonio M.
    Van Den Neste, Eric
    Liljeholm, Maria
    Ebrahim, Kurt S.
    Bedrosian, Camille L.
    Gao, Xiang
    Ames, Donna
    Socie, Gerard
    AMERICAN JOURNAL OF HEMATOLOGY, 2016, 91 (03) : E16 - E17
  • [44] Effect of Eculizumab on Physician-Reported Symptoms in the Russian Cohort of the Paroxysmal Nocturnal Hemoglobinuria (PNH) International Registry
    Lisukov, Igor
    Kulagin, Alexander
    Maschan, Alexey
    Shilova, Elena
    Abdulkadyrov, Kudrat
    Zaritskiy, Andrey
    Ivanova, Valentina
    Bogdanova, Yulia
    Volkova, Svetlana
    Gavrilenko, Andrey
    Kaporskaya, Tatyana
    Meresiy, Sergey
    Schneider, Tatyana
    Yakupova, Svetlana
    Anchukova, Ludmila
    Bakirov, Bulat
    Kosacheva, Natalia
    Krinitsina, Tatiana
    Ustyantseva, Viktoria
    Shatokhin, Yuriy
    Vinogradova, Elena
    Kazankova, Tatiana
    Rumyantsev, Alexander
    Afanasyev, Boris
    BLOOD, 2014, 124 (21)
  • [45] Early diagnosis and immediate treatment with eculizumab improves the outcome of Budd-Chiari syndrome (BCS) in paroxysmal nocturnal haemoglobinuria (PNH)
    Haughton, J.
    Kelly, R. J.
    Richards, S. J.
    Arnold, L. M.
    Wood, A.
    Downing, T.
    McKinley, C.
    Davies, M.
    Hillmen, P.
    Hill, A.
    BRITISH JOURNAL OF HAEMATOLOGY, 2013, 161 : 71 - 72
  • [46] Paroxysmal nocturnal hemoglobinuria (PNH): Long-term epidemiological study.
    de Latour, Regis Peffault
    Mary, Jean Y.
    Salanoubat, Celia
    Terriou, Louis
    Etienne, Gabriel
    Mohty, Mohamad
    Roth, Sophie
    de Guibert, Sophie
    Cahn, Jean Y.
    Socie, Gerard
    BLOOD, 2006, 108 (11) : 290A - 291A
  • [47] Lack of correlation of eculizumab therapy in paroxysmal nocturnal hemoglobinuria (PNH) patients with myeloproliferative disorders, myelodysplastic syndromes, acute leukemias or aplastic anemia with long-term treatment
    Schubert, J.
    Young, N. S.
    Luzzatto, L.
    Brodsky, R. A.
    Socie, G.
    Rother, R. P.
    Rollins, S. A.
    Hillmen, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [48] Prophylactic Antibiotic Use and Risk of Meningococcal Infections in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Treated with Eculizumab Who Received Meningococcal Vaccination: Results from the International PNH Registry
    Patriquin, Christopher J.
    Kulasekararaj, Austin
    de Latour, Regis Peffault
    Jang, Jun-Ho
    Langemeijer, Saskia
    Maschan, Alexey A.
    Wilson, Amanda
    Jain, Deepak
    Maciejewski, Jaroslaw P.
    BLOOD, 2019, 134
  • [49] Sustained response and long-term safety of eculizumab in paroxysmal nocturnal hemoglobinuria
    Hill, A
    Hillmen, P
    Richards, SJ
    Elebute, D
    Marsh, JC
    Chan, J
    Mojcik, CF
    Rother, RP
    BLOOD, 2005, 106 (07) : 2559 - 2565
  • [50] Diagnosis of an indolent malignant Nnon-Hodgkin lymphoma (NHL) in a patient with paroxysmal nocturnal hemoglobinuria (PNH) under long-term treatment with Eculizumab
    Bistritan, C. I.
    Theodoropoulou, S.
    Aul, C.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 258 - 258
12345